In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Derya Matras will be the new Vice President for Meta in Europe, Middle East and Africa, taking over from Angie Gifford, who announced that she will be leaving her role as VP of EMEA at the end of this ...

Before joining Enormous, Joy Chauhan was Managing Partner (North) and Chief Client Officer at JWT/Wunderman Thompson (now VML) ...

Sri Lanka’s leading e-commerce platform, Daraz, has officially launched its annual 11.11 shopping festival, known as the ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter €400 million upfront payment from ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...